Maito, Alfhaiser M.
HRN: 16-23-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CEFUROXIME 1.5GM (VIAL)
05/27/2023
06/03/2023
IVTT
470mg
Q8h
PCAP C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes